title: Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough?
authors.forename: Ikuo
authors.initials: I
authors.lastname: Hirano
mesh_terms: D000336:Aerosols / Q000008:administration & dosage*; D000730:Androstadienes / Q000008:administration & dosage*; D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D057765:Eosinophilic Esophagitis / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology*; D004804:Eosinophils / Q000473:pathology*; D005260:Female; D000068298:Fluticasone; D006801:Humans; D008297:Male
chemical_list: D000336:Aerosols; D000730:Androstadienes; D018926:Anti-Allergic Agents; D000068298:Fluticasone